Amgen Cholesterol Drug Patents Nixed, Undoing Jury Verdict
French drugmaker Sanofi scored a win Wednesday when a Delaware federal judge invalidated patents related to rival Amgen Inc.'s cholesterol-lowering drug Repatha, upending a February jury verdict that had gone largely...To view the full article, register now.
Already a subscriber? Click here to view full article